how to switch from tirzepatide to retatrutide Will Replace switching from retatrutide to tirzepatide

Whilst the market is currently led by Novo Nordisks semaglutide (Ozempic/Wegovy) and Eli Lillys tirzepatide (Mounjaro/Zepbound), stronger competition is expected with new entrants (Boehringer Ingelheim, Amgen, Pfizer, Roche amongst others) offering novel mechanisms (dual agonists, triple agonists and amylins), formulations (oral vs injectable) and dosing regimens (daily vs weekly vs monthly).

For example DPP4is and GLP1RAs both target the incretin pathway, which has been investigated since the 1960s for its involvement in postprandial energy metabolism (97)

2021;23(suppl 3):529

This approach allows your body to adjust to lower levels of GLP-1 support while you implement lifestyle changes to maintain your weight loss